細胞療法の世界市場レポート 2024

細胞療法の市場規模は、今後数年間で急速に成長すると予想されています。 2028年には15.1%の年間複合成長率（CAGR）で258億6,000万米ドルに成長すると予想されます。予測期間中に予想される成長は、倫理的および社会的考慮事項、投資と資金調達の動向、消費者/患者の需要、ヘルスケアインフラ、および急速なイノベーションサイクルに起因すると考えられます。予測期間中の主な動向には、個別化医療、標的治療の出現、遺伝子編集技術の進歩、幹細胞調査の拡大、免疫療法の画期的な進歩、微環境の操作などが含まれます。

細胞療法市場の拡大は、慢性疾患の有病率の増加によって促進されています。米国疾病管理予防センター（CDC）が定義する慢性疾患は、1年以上持続するもので、医師の診察が必要な場合、日常の活動が制限される場合、または両方の特徴を示す場合があります。心臓病、がん、糖尿病、パーキンソン病などの症状がこのカテゴリに分類されます。幹細胞は、脊髄損傷、1型糖尿病、パーキンソン病、心臓病、がん、変形性関節症と闘う患者に利益をもたらします。 CDCは2021年に、栄養不良と身体活動の不足により、米国の成人10人中6人が慢性疾患を患っており、10人中4人がそのような疾患を2つ以上経験していると報告しました。さらに、国際糖尿病連盟は、2030年までに世界中で約6億4,300万人が糖尿病になると予測しています。パーキンソン病などの慢性疾患の蔓延は細胞療法の需要にさらに寄与し、細胞療法市場の成長を促進します。

予想される投資の増加により、細胞療法市場の拡大が促進される見込みです。 細胞療法への投資には、細胞ベースの治療法の調査、開発、製造、商業化をサポートするための資金の割り当てが含まれます。この財政的支援は、新しい細胞療法製品と技術の進歩、およびそれらの有効性を評価するための臨床試験の実施を支援します。特に、Cell &Geneのレポートでは、細胞療法への投資が顕著に急増し、2020年の3億6,200万米ドルから2021年には680億米ドル近くまで急増していることが明らかになりました。この投資の大幅な増加は、細胞療法市場の成長の重要な推進力となっています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の細胞療法市場、技術別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 幹細胞療法
• 細胞ワクチン
• 養子細胞移植（ACT）
• 線維芽細胞療法
• 軟骨細胞療法
• 世界の細胞療法市場、治療タイプ別のセグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 同種療法
• 自己療法
• 世界の細胞療法市場、用途別セグメンテーション、実績および予測、2018-2023、2023-2028年、2033年
• 腫瘍学
• 心血管疾患（CVD）
• 整形外科
• 創傷治癒
• その他の用途

第7章 地域および国の分析

• 世界の細胞療法市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の細胞療法市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 細胞療法市場の競合情勢
• 細胞療法市場の企業プロファイル
  • Celgene Corporation
  • JCR Pharmaceuticals Co. Ltd.
  • Baxter Healthcare Corporation
  • Nipro Corporation
  • Stempeutics Research Pvt. Ltd.

第31章 その他の大手および革新的な企業

• Osiris Therapeutics Inc.
• Vericel Corporation
• AlloSource
• Anterogen Co. Ltd.
• Arteriocyte Medical Systems Inc.
• MediPost Co. Ltd.
• Pharmicell Co. Ltd.
• Corestem Inc.
• Stemedica Cell Technologies Inc.
• Adaptimmune Therapeutics plc
• Mesoblast Ltd.
• Cell Medica Ltd.
• Cellerant Therapeutics Inc.
• Kolon TissueGene Inc.
• Tego Science Inc.

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Cell therapy involves the replacement or repair of damaged tissue and/or cells by transplanting human cells. Various types of cells can be employed as part of a therapy or treatment for a range of diseases and disorders, leveraging new technologies, innovative products, and boundless imagination. This treatment form entails the administration of live cells to patients through injection, grafting, or implantation to achieve a therapeutic outcome.

The primary techniques employed in cell therapy include stem cell therapy, cell vaccines, adoptive cell transfer (ACT), fibroblast cell therapy, and chondrocyte cell therapy. Stem cell treatment, also recognized as regenerative medicine, utilizes stem cells or their derivatives to stimulate the healing response in diseased, defective, or injured tissues. Allogeneic therapies and autologous therapies are the two main types of therapies used in various applications such as oncology, cardiovascular disease (CVD), orthopedics, wound healing, and more.

The cell therapy market research report is one of a series of new reports from The Business Research Company that provides cell therapy market statistics, including cell therapy industry global market size, regional shares, competitors with a cell therapy market share, detailed cell therapy market segments, market trends and opportunities, and any further data you may need to thrive in the cell therapy industry. This cell therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The cell therapy market size has grown rapidly in recent years. It will grow from $12.58 billion in 2023 to $14.72 billion in 2024 at a compound annual growth rate (CAGR) of 17.0%. The growth observed in the historical period can be ascribed to early research and discoveries, regulatory milestones, clinical trials and studies, early adopters and pioneering companies, as well as market acceptance and perception.

The cell therapy market size is expected to see rapid growth in the next few years. It will grow to $25.86 billion in 2028 at a compound annual growth rate (CAGR) of 15.1%. The growth anticipated in the forecast period can be ascribed to ethical and societal considerations, trends in investment and funding, consumer/patient demand, healthcare infrastructure, and rapid innovation cycles. Key trends during the forecast period include personalized medicine, the emergence of targeted treatments, advancements in gene editing technologies, the expansion of stem cell research, breakthroughs in immunotherapy, and manipulation of the microenvironment.

The expansion of the cell therapy market has been facilitated by the increasing prevalence of chronic diseases. Chronic diseases, as defined by the US Centers for Disease Control and Prevention (CDC), persist for one year or more, necessitate medical attention, limit daily activities, or exhibit both characteristics. Conditions such as heart disease, cancer, diabetes, and Parkinson's disease fall under this category. Stem cells offer benefits to patients grappling with spinal cord injuries, type 1 diabetes, Parkinson's disease, heart disease, cancer, and osteoarthritis. The CDC reported in 2021 that poor nutrition and lack of physical activity have resulted in six out of ten adults in the USA suffering from chronic diseases, with four out of ten experiencing two or more such conditions. Moreover, the International Diabetes Federation projected that by 2030, approximately 643 million people worldwide will have diabetes. The prevalence of chronic diseases, such as Parkinson's, further contributes to the demand for cell therapies, fostering growth in the cell therapy market.

Anticipated growth in investments is poised to drive the expansion of the cell therapy market. Investment in cell therapy involves allocating financial resources to support research, development, manufacturing, and commercialization of cell-based therapies. This financial backing aids the advancement of new cell therapy products and technologies, as well as the execution of clinical trials to assess their efficacy. Notably, a report by Cell & Gene revealed a remarkable surge in cell therapy investment, soaring from $362 million in 2020 to nearly $68 billion in 2021. This substantial increase in investment is a key driver for the growth of the cell therapy market.

Despite the growing demand for cell therapies, the high cost associated with these treatments poses a significant hindrance to the cell therapy industry. While cell therapies have gained popularity, their expense remains a considerable barrier. Basic joint injections can cost around $1,000, while more specialized procedures can reach up to $100,000, depending on the condition. In the United States, the average cost of stem cell therapy in 2020 was estimated to range between $4,000 and $8,000 per patient. This financial barrier impedes the broader growth of the cell therapy market.

Key players in the cell therapy market are strategically engaging in partnerships and collaborations to expand their product portfolios and geographic reach. Takeda, a Japan-based pharmaceutical company, acquired GammaDelta Therapeutics, a US-based cell therapy company, in October 2021 to accelerate the development of allogeneic T cell therapies for solid tumors. Additionally, in June 2021, Charles River Laboratories, a US-based pharmaceutical company, acquired Vigene Biosciences Inc., a US-based biotech company, to enhance gene therapy capabilities and establish an end-to-end gene therapy solution in the US. This strategic approach is aimed at fostering long-term revenue and earnings growth potential.

Major companies in the cell therapy market are opting for strategic partnerships to deliver innovative and effective therapies. Genentech Inc., a US biotechnology corporation, partnered with Arsenal Biosciences, Inc., a US-based programmable cell therapy company, in September 2022. The collaboration aims to expedite the development of next-generation cell therapy products, particularly for solid tumors, potentially revolutionizing cancer treatment. This commitment to innovation and collaboration reflects a shared goal of advancing new and effective treatments for cancer patients.

In October 2021, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, acquired GammaDelta Therapeutics Limited for $100 million. This acquisition enabled Takeda to gain access to early-stage cell therapy programs and GammaDelta's allogeneic variable delta 1 (V1) gamma-delta T cell therapy platforms, encompassing both blood-derived and tissue-derived platforms. GammaDelta Therapeutics Limited, based in the UK, specializes in researching and developing T-cell therapy and immunotherapy for cancer treatment.

Major companies operating in the cell therapy market report are Celgene Corporation, JCR Pharmaceuticals Co. Ltd., Baxter Healthcare Corporation, Nipro Corporation, Stempeutics Research Pvt. Ltd., Osiris Therapeutics Inc., Vericel Corporation, AlloSource, Anterogen Co. Ltd., Arteriocyte Medical Systems Inc., MediPost Co. Ltd., Pharmicell Co. Ltd., Corestem Inc., Stemedica Cell Technologies Inc., Adaptimmune Therapeutics PLC, Mesoblast Ltd., Cell Medica Ltd., Cellerant Therapeutics Inc., Kolon TissueGene Inc., Tego Science Inc., Athersys Inc., 4D Molecular Therapeutics Inc., Abeona Therapeutics Inc., Forticell Bioscience Inc., Bone Therapeutics, Holostem Terapie Avanzate S.r.l, Fibrocell Science Inc., AlloCure Inc., TiGenix NV, Cells for Cells, AVROBIO Inc., Cellular Biomedicine Group Inc., Thermo Fisher Scientific Inc., Merck Co. & KGaA, Charles River Laboratories International Inc., Lonza Group Ltd., Catalent Inc.

North America was the largest region in the cell therapy market in 2023. The regions covered in the cell therapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell therapy market includes revenues earned by entities by enhancing the growth of new healthy skin tissue and enhancing collagen production. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Therapy Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Technique: Stem Cell Therapy; Cell Vaccine; Adoptive Cell Transfer (ACT); Fibroblast Cell Therapy; Chondrocyte Cell Therapy
• 2) By Therapy Type: Allogeneic Therapies; Autologous Therapies
• 3) By Application: Oncology; Cardiovascular Disease (CVD); Orthopedic; Wound Healing; Other Applications
• Companies Mentioned: Celgene Corporation; JCR Pharmaceuticals Co. Ltd.; Baxter Healthcare Corporation; Nipro Corp.; Stempeutics Research Pvt. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Cell Therapy Market Characteristics

3. Cell Therapy Market Trends And Strategies

4. Cell Therapy Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Cell Therapy Market Size and Growth

• 5.1. Global Cell Therapy Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Cell Therapy Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Cell Therapy Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Therapy Market Segmentation

• 6.1. Global Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Stem Cell Therapy
• Cell Vaccine
• Adoptive Cell Transfer (ACT)
• Fibroblast Cell Therapy
• Chondrocyte Cell Therapy
• 6.2. Global Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Allogeneic Therapies
• Autologous Therapies
• 6.3. Global Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oncology
• Cardiovascular Disease (CVD)
• Orthopedic
• Wound Healing
• Other Applications

7. Cell Therapy Market Regional And Country Analysis

• 7.1. Global Cell Therapy Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Cell Therapy Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Therapy Market

• 8.1. Asia-Pacific Cell Therapy Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Therapy Market

• 9.1. China Cell Therapy Market Overview
• 9.2. China Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Therapy Market

• 10.1. India Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Therapy Market

• 11.1. Japan Cell Therapy Market Overview
• 11.2. Japan Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Therapy Market

• 12.1. Australia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Therapy Market

• 13.1. Indonesia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Therapy Market

• 14.1. South Korea Cell Therapy Market Overview
• 14.2. South Korea Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Therapy Market

• 15.1. Western Europe Cell Therapy Market Overview
• 15.2. Western Europe Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Therapy Market

• 16.1. UK Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Therapy Market

• 17.1. Germany Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Therapy Market

• 18.1. France Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Therapy Market

• 19.1. Italy Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Therapy Market

• 20.1. Spain Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Therapy Market

• 21.1. Eastern Europe Cell Therapy Market Overview
• 21.2. Eastern Europe Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Therapy Market

• 22.1. Russia Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Therapy Market

• 23.1. North America Cell Therapy Market Overview
• 23.2. North America Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Therapy Market

• 24.1. USA Cell Therapy Market Overview
• 24.2. USA Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Therapy Market

• 25.1. Canada Cell Therapy Market Overview
• 25.2. Canada Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Therapy Market

• 26.1. South America Cell Therapy Market Overview
• 26.2. South America Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Therapy Market

• 27.1. Brazil Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Therapy Market

• 28.1. Middle East Cell Therapy Market Overview
• 28.2. Middle East Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Therapy Market

• 29.1. Africa Cell Therapy Market Overview
• 29.2. Africa Cell Therapy Market, Segmentation By Technique, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Cell Therapy Market, Segmentation By Therapy Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Cell Therapy Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Therapy Market Competitive Landscape And Company Profiles

• 30.1. Cell Therapy Market Competitive Landscape
• 30.2. Cell Therapy Market Company Profiles
  • 30.2.1. Celgene Corporation
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. JCR Pharmaceuticals Co. Ltd.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Baxter Healthcare Corporation
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Nipro Corporation
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Stempeutics Research Pvt. Ltd.
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Cell Therapy Market Other Major And Innovative Companies

• 31.1. Osiris Therapeutics Inc.
• 31.2. Vericel Corporation
• 31.3. AlloSource
• 31.4. Anterogen Co. Ltd.
• 31.5. Arteriocyte Medical Systems Inc.
• 31.6. MediPost Co. Ltd.
• 31.7. Pharmicell Co. Ltd.
• 31.8. Corestem Inc.
• 31.9. Stemedica Cell Technologies Inc.
• 31.10. Adaptimmune Therapeutics plc
• 31.11. Mesoblast Ltd.
• 31.12. Cell Medica Ltd.
• 31.13. Cellerant Therapeutics Inc.
• 31.14. Kolon TissueGene Inc.
• 31.15. Tego Science Inc.

32. Global Cell Therapy Market Competitive Benchmarking

33. Global Cell Therapy Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Therapy Market

35. Cell Therapy Market Future Outlook and Potential Analysis

• 35.1 Cell Therapy Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Cell Therapy Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Cell Therapy Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer